Early Life Intervention in Pediatrics Supported by E-health - SMOKE

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 5
SponsorInsel Gruppe AG, University Hospital Bern

About this trial

Unrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCDs in children, i.e. asthma. Early preventive measures to improve lifestyle behavior in parents are therefore of utmost importance. The aim of ELIPSE-II is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering levels of urinary cotinine as a measure of second-hand smoke exposure in their children .

Eligibility criteria

Qualifiers

Age: younger than 6 years

Exposed to second-hand smoke at home (at least one parent smoking)

German speaking parent

All sex and ethnic backgrounds

Disqualifiers

Participation in another study/trial targeting similar outcomes

Participation in an active smoking cessation programme

Trial design

Treatments tested in this trial

  • Life-Style app
  • Sham Comparator

Treatment groups

160 Participants
are divided into 2 treatment groups

Sponsors and collaborators